Wells Fargo & Company Innoviva, Inc. Put Options Transaction History
Wells Fargo & Company
- $407 Billion
- Q2 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding INVA
# of Institutions
222Shares Held
78.9MCall Options Held
20KPut Options Held
5.4K-
Black Rock Inc. New York, NY9.63MShares$193 Million0.0% of portfolio
-
Sarissa Capital Management LP Greenwich, CT7.28MShares$146 Million20.14% of portfolio
-
Franklin Resources Inc San Mateo, CA6.62MShares$132 Million0.03% of portfolio
-
Putnam Investments LLC Boston, MA6.27MShares$125 Million0.14% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.18MShares$124 Million0.0% of portfolio
About Innoviva, Inc.
- Ticker INVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 69,706,000
- Market Cap $1.39B
- Description
- Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...